Truist Financial Corp Has $879,000 Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

Truist Financial Corp reduced its holdings in U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating) by 20.1% during the 3rd quarter, HoldingsChannel reports. The firm owned 11,555 shares of the company’s stock after selling 2,901 shares during the quarter. Truist Financial Corp’s holdings in U.S. Physical Therapy were worth $879,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. SG Americas Securities LLC grew its position in shares of U.S. Physical Therapy by 39.0% in the second quarter. SG Americas Securities LLC now owns 11,850 shares of the company’s stock valued at $1,294,000 after purchasing an additional 3,323 shares during the last quarter. Shell Asset Management Co. grew its position in U.S. Physical Therapy by 58.2% during the second quarter. Shell Asset Management Co. now owns 1,354 shares of the company’s stock worth $148,000 after buying an additional 498 shares in the last quarter. Rice Hall James & Associates LLC grew its position in U.S. Physical Therapy by 0.7% during the second quarter. Rice Hall James & Associates LLC now owns 25,693 shares of the company’s stock worth $2,806,000 after buying an additional 182 shares in the last quarter. Boston Trust Walden Corp grew its position in U.S. Physical Therapy by 12.1% during the third quarter. Boston Trust Walden Corp now owns 509,446 shares of the company’s stock worth $38,728,000 after buying an additional 54,956 shares in the last quarter. Finally, Bridgewater Associates LP grew its position in U.S. Physical Therapy by 10.1% during the second quarter. Bridgewater Associates LP now owns 20,280 shares of the company’s stock worth $2,215,000 after buying an additional 1,866 shares in the last quarter. 98.44% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other U.S. Physical Therapy news, insider Eric Joseph Williams sold 590 shares of the firm’s stock in a transaction dated Monday, November 7th. The shares were sold at an average price of $86.04, for a total transaction of $50,763.60. Following the completion of the transaction, the insider now owns 8,864 shares in the company, valued at $762,658.56. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Eric Joseph Williams sold 590 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, November 7th. The shares were sold at an average price of $86.04, for a total value of $50,763.60. Following the completion of the transaction, the insider now owns 8,864 shares in the company, valued at $762,658.56. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Christopher J. Reading sold 5,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 5th. The shares were sold at an average price of $90.00, for a total transaction of $450,000.00. Following the completion of the transaction, the chief executive officer now owns 74,638 shares of the company’s stock, valued at approximately $6,717,420. The disclosure for this sale can be found here. Insiders sold a total of 15,893 shares of company stock worth $1,387,561 over the last quarter. Company insiders own 1.90% of the company’s stock.

U.S. Physical Therapy Stock Up 2.6 %

USPH stock opened at $94.24 on Friday. U.S. Physical Therapy, Inc. has a twelve month low of $73.30 and a twelve month high of $131.50. The company has a market cap of $1.23 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 3.11 and a beta of 1.28. The business’s 50-day simple moving average is $85.45 and its 200 day simple moving average is $89.42. The company has a quick ratio of 1.39, a current ratio of 1.39 and a debt-to-equity ratio of 0.46.

U.S. Physical Therapy (NYSE:USPHGet Rating) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.55 by $0.03. The firm had revenue of $139.60 million during the quarter, compared to analysts’ expectations of $136.41 million. U.S. Physical Therapy had a net margin of 7.34% and a return on equity of 12.30%. On average, research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.7 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 16th. Shareholders of record on Monday, November 21st were paid a dividend of $0.41 per share. This represents a $1.64 dividend on an annualized basis and a yield of 1.74%. The ex-dividend date was Friday, November 18th. U.S. Physical Therapy’s dividend payout ratio is 54.85%.

Wall Street Analyst Weigh In

Separately, StockNews.com assumed coverage on U.S. Physical Therapy in a research report on Wednesday, October 12th. They set a “hold” rating on the stock.

About U.S. Physical Therapy

(Get Rating)

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Stories

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPHGet Rating).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.